ATOS
Atossa Therapeutics·NASDAQ
--
--(--)
--
--(--)
ATOS Filings
Filing Date
Form Description
Form Type
2026-01-30
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
Ownership
2026-01-30 · Ownership
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
2026-01-26
Form 8-K - Current report
Key Events
2026-01-26 · Key Events
Form 8-K - Current report
2026-01-22
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-01-22 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-01-09
Form 8-K - Current report
Key Events
2026-01-09 · Key Events
Form 8-K - Current report
2026-01-06
Form 8-K - Current report
Key Events
2026-01-06 · Key Events
Form 8-K - Current report
2025-12-22
Form DEF 14A - Other definitive proxy statements
Key Events
2025-12-22 · Key Events
Form DEF 14A - Other definitive proxy statements
2025-12-12
Form PRE 14A - Other preliminary proxy statements
Key Events
2025-12-12 · Key Events
Form PRE 14A - Other preliminary proxy statements
2025-12-04
Form 8-K - Current report
Key Events
2025-12-04 · Key Events
Form 8-K - Current report
2025-11-12
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-11-12 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-11-12
Form 8-K - Current report
Key Events
2025-11-12 · Key Events
Form 8-K - Current report
